On Tuesday the CFTC cleared a contract that gives Americans leveraged, cash settled exposure to Apple, with no expiry date and no shares changing hands. In our industry, that's called a CFD.
Look at the terms. There's leverage, a financing cost to hold the position, cash settlement and no ownership of the stock. That's the product this industry has sold for two decades, and the one US retail clients were never allowed to trade. Now it's reaching them through US exchanges under a different name.
Three things happened this week in three jurisdictions, and they point the same way.
Start with Washington. CFTC Chairman Michael Selig said perpetual futures on individual stocks can trade on exchanges registered with both the CFTC and the SEC, classified as security futures. Kalshi, Coinbase Derivatives and Bitnomial filed in September. Kalshi's filing covers up to 58 names, including Apple, Nvidia and Tesla. CFTC statement · Bankless summary
The onshore version is restrained. As filed, the contracts trade from Sunday evening to Friday afternoon rather than around the clock, with margin floors around 15%, roughly 6.5x leverage. No venue has named a launch date.
The pushback has already started. CME is suing the CFTC, arguing perps are swaps rather than futures. A group backed by Cboe and Citadel Securities has filed its own challenge. SIFMA asked regulators to pause, and Better Markets called the product gambling in disguise. Bankless · Finimize
On Thursday, Axi, a global FX and CFD broker, launched perpetual futures on OpenAI and Anthropic. Clients can go long or short, trade seven days a week and use leverage of up to 25:1. They get price exposure to two private companies before they list, with no shares and no IPO allocation. Axi announcement ·
In the Netherlands, the AFM's position on prop firms was back in the trade press this week. In the Ufunded case, the regulator ruled that the firm's model was CFD trading, which makes it an investment service that needs a licence. By the time the AFM stepped in, 1,279 Dutch investors had sent Ufunded more than €20 million. AFM on Ufunded
Each regulator used a different label for the same exposure.
Are regulators looking past the label?
For years the industry argued about what a CFD is. In 2018, ESMA capped retail leverage because it decided the product itself was the problem.
This week looks different. The CFTC looked at a leveraged, no expiry stock contract and approved it for its own exchanges. The AFM looked at a prop firm challenge and called it a CFD that needs a licence. CME looked at the same perp the CFTC approved and argued it's a swap, so the CFTC is the wrong regulator. None of them disputes what the product does. They disagree on who supervises it.
For brokers, that matters. If the product is the same everywhere, the advantage sits with whoever holds the licence to sell it in a given market.
Why does the leverage gap matter?
Put the two launches side by side. The US version, as filed, trades Sunday evening through Friday afternoon on listed large caps at roughly 6.5x. Axi's contracts trade around the clock at up to 25:1, on two companies that aren't public yet.
That gap decides where volume goes. Retail derivatives have been shaped by leverage caps for years. Crypto venues listed pre IPO perps first, and the volume followed: pre IPO perpetual volumes across exchanges reached $12 billion in June, up from $2 million in March, according to CryptoQuant data. Binance alone took $10.3 billion of it. CryptoQuant figures via BabyPips
That's real demand, and it went to whoever listed the product first. When a regulated CFD broker lists the same private company exposure with weekend hours, I see a broker going after volume Binance has had to itself.
What does this mean for CFD brokers?
First, the US is opening up to exchanges, not to CFD brokers. The onshore perp is an exchange product with clearing and dual registration. The front runners are Coinbase, Kalshi and Bitnomial, plus whoever else gets both approvals. A CySEC or ASIC licence counts for nothing there.
Polymarket shows where this can go. This week it won NFA approval to run a futures broker, which gives it an exchange, a clearinghouse and a broker in house. Positions are fully collateralised for now, so there's no leverage yet. If it gets margin approval, it can offer leveraged products with no CFD broker involved. Finance Magnates
Second, US stock exposure stops being a selling point. Crypto venues such as Hyperliquid already list stock perps for non US clients, and US exchanges will soon offer the same contract at home. When the same exposure comes in several wrappers, offering CFDs on US stocks won't win clients by itself. Brokers will compete on execution, pricing, coverage, trading hours and brand.
Third, the top of the market keeps changing hands. Finance Magnates Intelligence data shows the top five CFD brokers held the same 38% volume share in Q4 2025 as in Q4 2021, while total volume rose 173%. Three of those five names were new. I'd expect brokers that list new products early to compete for those spots, and Axi just did. FM Intelligence
Where does this leave us?
The lawsuits could take a while, and CME may win. Even then, the same exposure is already available on crypto venues and CFD platforms, and it will be on US exchanges once a venue launches. Brokers who rely on the word "CFD" to set them apart will find their clients trading Tesla somewhere else.
If Washington can sell a CFD and call it a future, how long before your clients stop caring what you call yours?
Alex
Observed
What changed
Three regulators looked at the same leveraged product this week and gave it three different names.
Method
How this record was read
- Why now · editorial reading
- Filed 06 Nov 2026 · CFD desk · 5 min read. This is when the desk judged the move worth writing up — the dispatch body carries the reasoning.
- The tactic worth testing · editorial reading
- No tactic is claimed here unless the dispatch states one.
- Open question · editorial reading
- Does this hold as CFD distribution keeps moving, or is it specific to this cycle?
